Literature DB >> 6140740

Selective primary health care: strategies for control of disease in the developing world. X. Amebiasis.

A Martínez-Palomo, M Martínez-Báez.   

Abstract

The human parasite Entamoeba histolytica has a worldwide distribution. The majority of infected individuals suffer few symptoms; nonetheless, a variable proportion experience dysentery, hepatic abscesses, or invasion of other extraintestinal organs. Invasive amebiasis is a major health problem, particularly in certain developing countries. The aim of this review is to clarify, as much as possible, controversial issues about the biology of the parasite, the clinical features of amebiasis, and the estimations of morbidity and mortality rate as the basis for defining strategies for control of amebiasis by primary health care workers. The eradication of invasive amebiasis lies basically in potentially political and economic actions at the governmental level. Preventive and control measures include (1) provision of water supplies and sanitation, (2) health education, (3) adequate diagnosis and correct treatment of invasive amebiasis, and (4) implementation of surveillance and control programs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140740     DOI: 10.1093/clinids/5.6.1093

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  14 in total

1.  Involvement of p21racA, phosphoinositide 3-kinase, and vacuolar ATPase in phagocytosis of bacteria and erythrocytes by Entamoeba histolytica: suggestive evidence for coincidental evolution of amebic invasiveness.

Authors:  S K Ghosh; J Samuelson
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Antiamoebic and toxicity studies of a carbamic acid derivative and its therapeutic effect in a hamster model of hepatic amoebiasis.

Authors:  Cynthia Ordaz-Pichardo; Mineko Shibayama; Saúl Villa-Treviño; Myriam Arriaga-Alba; Enrique Angeles; Mireya de la Garza
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  [Amebiasis and the anti-ameba campaign].

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

4.  Polymerase chain reaction confirmation of diagnosis of intestinal amebiasis in Puducherry.

Authors:  Subhash Chandra Parija; Atul Garg; K Pushpa; Krishna Khairnar; T Priya
Journal:  Indian J Gastroenterol       Date:  2010-09-03

5.  Molecular epidemiology of Entamoeba spp.: evidence of a bottleneck (Demographic sweep) and transcontinental spread of diploid parasites.

Authors:  S Ghosh; M Frisardi; L Ramirez-Avila; S Descoteaux; K Sturm-Ramirez; O A Newton-Sanchez; J I Santos-Preciado; C Ganguly; A Lohia; S Reed; J Samuelson
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

6.  Autophagy during proliferation and encystation in the protozoan parasite Entamoeba invadens.

Authors:  Karina Picazarri; Kumiko Nakada-Tsukui; Tomoyoshi Nozaki
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

7.  Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers.

Authors:  J C Samuelson; A Burke; J M Courval
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

8.  Amoebiasis and its control.

Authors:  A Davis; Z S Pawlowski
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  Cloning and expression of an NADP(+)-dependent alcohol dehydrogenase gene of Entamoeba histolytica.

Authors:  A Kumar; P S Shen; S Descoteaux; J Pohl; G Bailey; J Samuelson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 10.  Laboratory diagnostic techniques for Entamoeba species.

Authors:  R Fotedar; D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.